The EUROPA Trial: Design, Baseline Demography and Status of the Substudies

@article{Gomma2001TheET,
  title={The EUROPA Trial: Design, Baseline Demography and Status of the Substudies},
  author={Abba H. Gomma and Kim M. Fox},
  journal={Cardiovascular Drugs and Therapy},
  year={2001},
  volume={15},
  pages={169-179}
}
Background: Angiotensin-converting enzyme inhibitors do reduce both mortality and morbidity in patients with left ventricular dysfunction, recent myocardial infarction and hypertension. However, the long-term effects in patients with coronary artery disease have not been established. The EUROPA study is designed to assess the long-term (3–4 years) effects of perindopril on the reduction of cardiac events in patients with proven stable coronary artery disease but with no evidence of heart… CONTINUE READING